PLRX
NASDAQ · Pharmaceuticals
Pliant Therapeutics Inc
$1.13
+0.02 (+1.35%)
Open$1.12
Previous Close$1.11
Day High$1.13
Day Low$1.11
52W High$1.95
52W Low$1.02
Volume—
Avg Volume446.7K
Market Cap69.97M
P/E Ratio—
EPS$-2.43
SectorPharmaceuticals
Analyst Ratings
Strong Sell
10 analysts
Price Target
+1,418.2% upside
Current
$1.13
$1.13
Target
$17.08
$17.08
$13.48
$17.08 avg
$25.30
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.16M | 13.79M | 14.54M |
| Net Income | 3.08M | 2.65M | 3.08M |
| Profit Margin | 20.3% | 19.2% | 21.2% |
| EBITDA | 5.59M | 4.59M | 4.96M |
| Free Cash Flow | 2.06M | 2.45M | 2.36M |
| Rev Growth | +19.0% | -9.0% | -2.1% |
| Debt/Equity | 0.34 | 0.31 | 0.34 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |